122 related articles for article (PubMed ID: 21568213)
61. Expression in Escherichia coli, refolding, and purification of the recombinant mature form of human matrix metalloproteinase 7 (MMP-7).
Muta Y; Yasui N; Matsumiya Y; Kubo M; Inouye K
Biosci Biotechnol Biochem; 2010; 74(12):2515-7. PubMed ID: 21150109
[TBL] [Abstract][Full Text] [Related]
62. Purification and on-column refolding of a single-chain antibody fragment against rabies virus glycoprotein expressed in Escherichia coli.
Xi H; Yuan R; Chen X; Gu T; Cheng Y; Li Z; Jiang C; Kong W; Wu Y
Protein Expr Purif; 2016 Oct; 126():26-32. PubMed ID: 27157441
[TBL] [Abstract][Full Text] [Related]
63. Refolding and purification of Zymomonas mobilis levansucrase produced as inclusion bodies in fed-batch culture of recombinant Escherichia coli.
Sunitha K; Chung BH; Jang KH; Song KB; Kim CH; Rhee SK
Protein Expr Purif; 2000 Apr; 18(3):388-93. PubMed ID: 10733894
[TBL] [Abstract][Full Text] [Related]
64. A rapid method for analyzing recombinant protein inclusion bodies by mass spectrometry.
Grimm R; Huber R; Neumeier T; Seidl A; Haslbeck M; Seibert FS
Anal Biochem; 2004 Jul; 330(1):140-4. PubMed ID: 15183772
[TBL] [Abstract][Full Text] [Related]
65. Approaches for the generation of active papain-like cysteine proteases from inclusion bodies of Escherichia coli.
Ling C; Zhang J; Lin D; Tao A
World J Microbiol Biotechnol; 2015 May; 31(5):681-90. PubMed ID: 25792298
[TBL] [Abstract][Full Text] [Related]
66. Recombinant Glargine Insulin Production Process Using
Hwang HG; Kim KJ; Lee SH; Kim CK; Min CK; Yun JM; Lee SU; Son YJ
J Microbiol Biotechnol; 2016 Oct; 26(10):1781-1789. PubMed ID: 27363479
[TBL] [Abstract][Full Text] [Related]
67. Characterization and functional recovery of a novel antimicrobial peptide (CECdir-CECret) from inclusion bodies after expression in Escherichia coli.
Schmitt P; Mercado L; Díaz M; Guzmán F; Arenas G; Marshall SH
Peptides; 2008 Apr; 29(4):512-9. PubMed ID: 18325631
[TBL] [Abstract][Full Text] [Related]
68. High-level expression and efficient refolding of therapeutically important recombinant human Interleukin-3 (hIL-3) in E. coli.
Dagar VK; Adivitiya ; Khasa YP
Protein Expr Purif; 2017 Mar; 131():51-59. PubMed ID: 27864159
[TBL] [Abstract][Full Text] [Related]
69. Practical applications of hydrostatic pressure to refold proteins from inclusion bodies for NMR structural studies.
Ogura K; Kobashigawa Y; Saio T; Kumeta H; Torikai S; Inagaki F
Protein Eng Des Sel; 2013 Jun; 26(6):409-16. PubMed ID: 23525046
[TBL] [Abstract][Full Text] [Related]
70. Expression and purification of biologically active recombinant human paraoxonase 1 from inclusion bodies of Escherichia coli.
Bajaj P; Tripathy RK; Aggarwal G; Pande AH
Protein Expr Purif; 2015 Nov; 115():95-101. PubMed ID: 26003526
[TBL] [Abstract][Full Text] [Related]
71. Development of a rapid high-efficiency scalable process for acetylated Sus scrofa cationic trypsin production from Escherichia coli inclusion bodies.
Zhao M; Wu F; Xu P
Protein Expr Purif; 2015 Dec; 116():120-6. PubMed ID: 26318238
[TBL] [Abstract][Full Text] [Related]
72. High cell density cultivation of recombinant Escherichia coli for prodrug of recombinant human GLPs production.
Zhou Y; Ma X; Hou Z; Xue X; Meng J; Li M; Jia M; Luo X
Protein Expr Purif; 2012 Sep; 85(1):38-43. PubMed ID: 22771632
[TBL] [Abstract][Full Text] [Related]
73. Matrix-assisted refolding of oligomeric small heat-shock protein Hsp26.
Franzmann TM
Int J Biol Macromol; 2006 Aug; 39(1-3):104-10. PubMed ID: 16626802
[TBL] [Abstract][Full Text] [Related]
74. Probing of some compounds as anti-aggregatory additives in the protein refolding process from Escherichia coli inclusion bodies.
Zilinskas A; Sereikaite J
Biotechnol Appl Biochem; 2011; 58(4):277-84. PubMed ID: 21838803
[TBL] [Abstract][Full Text] [Related]
75. Exploring the nature of inclusion bodies by MALDI mass spectrometry using recombinant proinsulin as a model protein.
Gardner QA; Hassan N; Hafeez S; Arif M; Akhtar M
Int J Biol Macromol; 2019 Oct; 139():647-653. PubMed ID: 31356950
[TBL] [Abstract][Full Text] [Related]
76. Characterization of recombinant pectate lyase refolded from inclusion bodies generated in E. coli BL21(DE3).
Kumar S; Jain KK; Singh A; Panda AK; Kuhad RC
Protein Expr Purif; 2015 Jun; 110():43-51. PubMed ID: 25497420
[TBL] [Abstract][Full Text] [Related]
77. Expression, refolding, and characterization of human soluble BAFF synthesized in Escherichia coli.
Cao P; Mei JJ; Diao ZY; Zhang Sq
Protein Expr Purif; 2005 May; 41(1):199-206. PubMed ID: 15802238
[TBL] [Abstract][Full Text] [Related]
78. Solvent extraction of recombinant interferon alpha-2b from inclusion bodies and efficient refolding at high protein concentrations.
Mousavi SB; Davarpanah SJ
Protein Expr Purif; 2022 Sep; 197():106110. PubMed ID: 35577182
[TBL] [Abstract][Full Text] [Related]
79. [Application of a prediction model in inclusion body refolding].
Zhang T; Wang JF; Feng YY; Yang Z; Ma L; Wang XN
Nan Fang Yi Ke Da Xue Xue Bao; 2009 Nov; 29(11):2156-60. PubMed ID: 19923054
[TBL] [Abstract][Full Text] [Related]
80. Expression, purification, refolding and in vitro recovery of active full length recombinant human gelatinase MMP-9 in Escherichia coli.
Mohseni S; Moghadam TT; Dabirmanesh B; Khajeh K
Protein Expr Purif; 2016 Oct; 126():42-48. PubMed ID: 27164034
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
